메뉴 건너뛰기




Volumn 37, Issue 1, 2005, Pages 57-63

A stability indicating LC method for Rivastigmine hydrogen tartrate

Author keywords

Alzheimer's disease; Forced degradation; Pharmaceutical dosage form; Rivastigmine hydrogen tartrate; RPLC; Solution and mobile phase stability; Validation

Indexed keywords

3 (1 DIMETHYLAMINOETHYL)PHENOL; ACETONITRILE; HYDROCHLORIC ACID; HYDROGEN PEROXIDE; PHENOL DERIVATIVE; RIVASTIGMINE; SODIUM HYDROXIDE; UNCLASSIFIED DRUG;

EID: 12344324779     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.09.041     Document Type: Article
Times cited : (41)

References (8)
  • 2
    • 0001815909 scopus 로고
    • Pathology of Alzheimer's disease
    • D.B. Calne Philadelphia WB Sanders
    • H. Braak, and E. Braak Pathology of Alzheimer's disease D.B. Calne Neurodegenerative Diseases 1994 Philadelphia WB Sanders 565 613
    • (1994) Neurodegenerative Diseases , pp. 565-613
    • Braak, H.1    Braak, E.2
  • 7
    • 12344285759 scopus 로고    scopus 로고
    • Stability testing of new drug substances and products (Q1AR)
    • IFPMA, Geneva
    • ICH Stability testing of new drug substances and products (Q1AR) International Conference on Harmonization IFPMA, Geneva 2000
    • (2000) International Conference on Harmonization
    • Ich1
  • 8
    • 0003228192 scopus 로고
    • ICH Draft Guidelines on Validation of Analytical Procedures: Definitions and Terminology
    • IFPMA, Switzerland
    • ICH Draft Guidelines on Validation of Analytical Procedures: Definitions and Terminology, Federal Register, vol. 60, IFPMA, Switzerland, 1995, p. 11260.
    • (1995) Federal Register , vol.60 , pp. 11260


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.